Nu Skin Enterprises (NYSE:NUS) Releases Quarterly Earnings Results, Misses Estimates By $0.11 EPS

Nu Skin Enterprises (NYSE:NUS) posted its quarterly earnings results on Friday. The company reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.21 by ($0.11), FiscalAI reports. The company had revenue of $311.01 million during the quarter, compared to analysts’ expectations of $328.70 million. Nu Skin Enterprises had a positive return on equity of 6.58% and a negative net margin of 15.73%. Nu Skin Enterprises updated its FY 2026 guidance to 0.550-0.650 EPS.

Nu Skin Enterprises Stock Performance

Shares of Nu Skin Enterprises stock traded down $0.43 during trading hours on Friday, reaching $4.09. 896,360 shares of the stock traded hands, compared to its average volume of 576,157. The company has a 50 day moving average price of $4.77 and a 200 day moving average price of $6.30. The firm has a market capitalization of $199.33 million, a price-to-earnings ratio of -0.92 and a beta of 0.92. Nu Skin Enterprises has a one year low of $4.09 and a one year high of $11.67. The company has a quick ratio of 1.24, a current ratio of 1.98 and a debt-to-equity ratio of 0.36.

Nu Skin Enterprises Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 9th. Shareholders of record on Friday, November 27th will be given a $0.06 dividend. This represents a $0.24 annualized dividend and a yield of 5.9%. The ex-dividend date of this dividend is Friday, November 27th. Nu Skin Enterprises’s dividend payout ratio (DPR) is presently -5.37%.

Nu Skin Enterprises News Roundup

Here are the key news stories impacting Nu Skin Enterprises this week:

• Positive Sentiment: Nu Skin declared a quarterly dividend of $0.06 per share, payable December 9 to shareholders of record November 27. The annualized payout is $0.24 per share. Nu Skin Enterprises company information
• Neutral Sentiment: Management’s 2026 revenue guidance of $1.3 billion was in line with consensus, though it does not imply a near-term recovery in sales. Nu Skin reports third-quarter earnings
• Negative Sentiment: Third-quarter results missed estimates: revenue was $311.0 million versus $328.7 million expected, and adjusted EPS was $0.10 versus the $0.21 consensus. Revenue fell 14.6% year over year; customers, paid affiliates, and sales leaders also declined. Nu Skin Q3 earnings and revenues lag estimates
• Negative Sentiment: Nu Skin forecast 2026 EPS of $0.55–$0.65, below the $0.82 consensus estimate, signaling lower expected profitability. The company reported a GAAP loss of $0.02 per share for the quarter, compared with $0.34 EPS a year earlier. Nu Skin reports third-quarter earnings

Analysts Set New Price Targets

Several equities analysts recently issued reports on NUS shares. Zacks Research raised Nu Skin Enterprises from a “strong sell” rating to a “hold” rating in a research report on Monday, October 12th. Weiss Ratings lowered Nu Skin Enterprises from a “sell (d+)” rating to a “sell (d)” rating in a report on Tuesday, August 11th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Nu Skin Enterprises presently has a consensus rating of “Reduce”.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a global direct-selling company that develops and distributes personal care and wellness products. Its portfolio includes skincare, beauty and personal care products, nutritional supplements, and wellness-related devices and technologies. The company markets products under brands including Nu Skin and Pharmanex, with its ageLOC product line focused on skincare and age-related wellness.

Founded in 1984 and headquartered in Provo, Utah, Nu Skin sells its products primarily through a network of independent distributors, supported by digital commerce and other direct-to-consumer channels.